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CHAPTER I 
 
INTRODUCTION 
 
Retina 
The retina, often referred to as an extension of the brain, is an integral part 
of the perception of sight. It is located in the posterior portion of the eye and 
consists of 10 layers. The ganglion cell layer is located adjacent to the vitreous. 
The inner limiting membrane separates these two layers. Posterior to the 
ganglion cells lays the inner plexiform layer, inner nuclear layer, outer plexiform 
layer, outer nuclear layer, photoreceptors, and retinal pigment epithelium (RPE). 
The inner nuclear layer is composed of horizontal, bipolar, and amacrine cell 
nuclei. Horizontal cells lie on the outer margin of the inner nuclear layer. Bipolar 
cells can be found in the middle of this layer, and amacrine cells are located on 
its proximal border abutting the ganglion cells. The axons of bipolar and 
amacrine cells make up the inner plexiform layer. The cell bodies of 
photoreceptors comprise the outer nuclear layer, and their axons make up the 
outer plexiform layer. Bipolar and horizontal cells also extend their processes into 
the outer plexiform layer. The external limiting membrane separates the outer 
nuclear layer from the photoreceptors, and the RPE, located in the back of the 
eye, regulates the flow of molecules between the circulation of the choroid and 
the neural retina [1] (Figure 1). 
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Figure 1. Histological and schematic [2] representations of the retina 
 
When light enters the eye, it passes through the various layers of the 
retina to reach the photoreceptors where the visual transduction cascade is 
initiated. Information is relayed back through the outer layers of the retina to 
bipolar cells. Bipolar cells then transmit the signal to the ganglion cells, which 
then send the information to the brain via the optic nerve. Horizontal and 
amacrince cells serve to regulate the neural signal. Horizontal cells provide 
negative feedback for the photoreceptors to regulate the degree of excitation of 
the bipolar cells. Amacrine cells provide negative feedback for local signals at the 
inner nuclear level. These cells collect signals from multiple bipolar cells and 
regulate the flow of information relayed from the bipolar cells to the ganglion cells 
[1].  
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Insulin signaling, receptors, and substrates 
Insulin, the most potent anabolic hormone known to date, promotes the 
synthesis and storage of carbohydrates, lipids, and proteins and inhibits their 
degradation and release into the body’s circulation. The mechanisms of insulin 
action are complex. Consumption of food produces a rise in glucose levels, 
which triggers the release of insulin from the β cells of the pancreas. Insulin 
increases the uptake and use of glucose by skeletal muscle and fat cells by 
stimulating the translocation of the glucose transporter GLUT4 from intracellular 
sites to the cell surface [3]. The hormone also suppresses lipolysis in adipose 
tissue, and glucose production and ketogenesis by liver [4]. 
Insulin receptors are present in almost all vertebrate tissues. Embedded in the 
plasma membrane of cells, the receptors consist of two α subunits linked to two β 
subunits and each other by disulfide bonds. α subunits are extracellular and 
contain the insulin binding sites, and β subunits are intracellular and contain the 
insulin-regulated tyrosine protein kinase (Figure 2). Insulin binds to the α subunits 
and causes a conformational change of the dimer. This activates tyrosine 
kinases, which cause the autophosphorylation of tyrosine residues on the 
intracellular β subunits. Tyrosine kinase activity is crucial for insulin action. 
Naturally occurring mutations of insulin receptors that inhibit kinase activity are 
associated with severe insulin resistance. Once the β domains have been 
autophosphorylated, they can then catalyze the phosphorylation of cellular 
proteins such as insulin receptor substrates (IRS) 1 and 2. IRS proteins then 
interact with signaling molecules and cause the activation of PI3 kinase and other 
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cascades. The receptor structure and signaling mechanisms are similar for 
insulin-like growth factor (IGF) 1 [6]. 
 
 
 
 
 
 
       
 
Figure 2. Insulin receptor [5] 
 
Correct functioning of insulin signaling pathways is important for 
maintaining healthy blood glucose levels. It also helps prevent the retinopathy, 
nephropathy, neuropathy, and vascular changes associated with hyperglycemia. 
However, insulin resistance has also been documented to extend lifespan in 
animals such as C. elegans, Drosophila, and mice [7-9].  
 
Insulin and the retina 
Insulin receptors have been shown to be expressed in all layers of human, 
bovine, and rodent retinas [10, 11]. This includes neural as well as endothelial 
and RPE cells. Endothelial cell and pericytes have specific binding affinity for 
insulin, and insulin receptors on the basolateral surface of RPE cells may have a 
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role in one-way insulin transport to photoreceptors. Due to the relatively constant 
levels of insulin in the brain despite fluctuating levels in peripheral circulation, 
some scientists hypothesize that the insulin signaling pathway in the retina is 
always active and does not change with nutritional state. They further conjecture 
that this constant signal is required for proper development of the retina and 
continued cell survival [10].  
 
Diabetes 
  Diabetes mellitus is characterized by deficient insulin action [10], and is 
projected to affect over 221 million people worldwide by 2010 [12].The disease 
results from the body’s lack of insulin or failure to compensate for diminished 
insulin response and is usually characterized by high levels of circulating 
glucose. Type I or insulin dependent diabetes is an autoimmune disorder in 
which the β cells of the pancreas fail to produce insulin. It is often hereditary and 
accounts for about 10% of patients. Type II or noninsulin dependent diabetes 
comprises the majority of cases and is frequently seen in obese individuals [6].  
These sufferers have become resistant to insulin or are not producing enough of 
the hormone to meet their metabolic needs. The Greek physician, Aretaeus, first 
used the term diabetes in the 2nd century A.D. It means “to siphon” and refers to 
how the disease can rapidly drain fluid from a person’s body. Mellitus was added 
in the late 1700’s by William Cullen. This adjective means “honey” and describes 
the sweetness of the blood and urine of diabetics. Until the 1900’s, no reliable 
treatment existed for this condition. However, canine research conducted in the 
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early part of the century allowed scientists to create the first insulin extract, which 
then could be administered to prolong the life of the animals. Further progress 
came rapidly and by 1978, human insulin had been synthesized [13]. 
 
Diabetic Retinopathy 
Diabetic retinopathy is one of the most common complications of diabetes 
and was first described by Jaeger in 1855 [13]. This ocular manifestation of 
diabetes mellitus has both vascular and neural components. Microaneurysms 
and dot hemorrhages are common early vascular changes. Microaneurysms are 
sac-like outpouchings from the sides of cellular capillaries. They have distinct 
margins and appear as round red spots in ophthalmologic exams. They can 
become completely acellular and are thought to be a secondary reaction to 
retinal hypoxia [4]. Hemorrhages are round red spots with indistinct borders and 
may appear globular or feathered depending on their location in the retina. 
Exudates are another clinical sign of diabetic retinopathy. Hard exudates are 
characterized as small, pale yellow lesions with distinct borders. These lipid-filled 
masses are found in the body of the retina and usually appear in areas with 
leaking capillaries. Soft exudates are pale yellow lesions on the surface of the 
retina.  Often called cotton wool spots, they are indicative of neural infarcts and 
not really exudates at all [4]. Neuronal degeneration of all cell types in the retina 
has also been observed [14-19].  
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Klotho 
                                                                       
Klotho was first discovered when Kuro-o and his colleagues attempted to 
insert a sodium–proton exchanger into C3HxC57BL/6F1 mice. Mice homozygous 
for the insertional transgene exhibited several phenotypes resembling human 
aging such as arteriosclerosis, osteoporosis, skin atrophy, ectopic calcification of 
certain soft tissues, a shortened life span, and infertility. Subsequent studies 
found that the insertional mutation disrupted the 5’ promoter region of the klotho 
(kl) gene. The kl mutation does not disrupt the coding structure of the gene but 
severely reduces its expression[20].  
Kl (-/-) mice develop normally up to three or four weeks of age and are 
indistinguishable from their wild type litter mates (+/+ or kl/+). At such time, they 
then begin to show growth retardation, become inactive and die between eight 
and nine weeks of age [20]. Age-related changes have been observed in many 
tissues of the klotho knockout mouse such as the lungs, skin, bone, and 
stomach, but the actual protein has been localized to only a few organs. These 
organs include the pituitary gland, placenta, skeletal muscle, bladder, aorta, 
pancreas, testis, ovary, colon, and thyroid gland. The human homologue has 
only been detected in the kidney, placenta, prostate, and small intestine [21]. 
Due to the limited number of tissues expressing klotho in the body and the 
manifestation of its effects on a number of organs, scientists hypothesized that 
the protein or some unidentified associated factors produce its effect through the 
circulatory system. To date, klotho appears to have a role in regulating calcium, 
 8 
 
 
phosphorus, 1,25-(OH)2 Vitamin D3 [3], and glucose. The exact biological and 
molecular mechanisms, however, have yet to be elucidated [22]. 
 The mouse klotho gene encodes a single-pass membrane protein of        
1,014 amino acids (a.a.), which consists of a N-terminal signal sequence, a 
putative extracellular domain with two internal repeats (KL1 and KL2), a single 
membrane spanning region, and a short intracellular region (Figure 3).  
 
 
 
 
Figure 3. Structure of the klotho protein [22] 
 
The internal repeats share homology with β-glucosidase enzymes. The human 
homologue of klotho is 1,012 (a.a.) in length. It has been determined that the 
extracellular domain is shed from the cell surface and is detectable in blood and 
cerebrospinal fluid of humans and mice [23]. The protein has a short stretch of 
basic amino acids (lys-lys-arg-lys) between the two internal repeats of the 
extracellular domain in both mouse and human that is a possible site for the 
proteolytic cleavage.  A splice variant of the kl mRNA also exists which encodes 
for a secreted protein ~ 550 a.a. long in mice and humans. This form lacks the 
second internal repeat (KL2), the transmembrane domain and the intracellular 
domain. The secreted splice variant form of klotho has been found to 
predominate over the membrane form in all tissues examined in humans. The 
KL1 KL2
TMSS 
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inverse is true in wild type mice where membrane-bound klotho expression is 10 
or more times greater than the splice variant [24].  
Klotho has been shown to extend the lifespan of EFmKL46 and EFmKL48 
mice, animals genetically engineered to overexpress the protein, through the 
reduction of insulin/IGF1 signaling [25]. The mechanism is believed to be the 
suppression of tyrosine phosphorylation of insulin/IGF1 receptors. Klotho does 
not affect the binding of insulin to its cell surface receptors but suppresses 
ligand-stimulated autophosphorylation of the receptors in a dose dependent 
manner. The net effect of klotho overproduction is reduced IRS activity and 
reduced association with PI-3 kinase [25].  Male EFmKL46 and EFmKL48 mice 
outlive wild type mice by 20.0% and 30.8% respectively and 18.8% and 19.0% 
respectively in females [25]. Male klothos are hyperinsulinemic and insulin 
resistant. Male and female mice are resistant to the hypoglycemic action of IGF-1 
[26], have reduced GLUT4 translocation to the plasma membrane [27], and are 
not hyperglycemic. Thus, klotho blocks insulin signaling in a manner similar to 
the loss of insulin signaling seen in insulin resistance [27].   
 
Specific aims 
To date, no published works exist that document the effects altered insulin 
signaling induced by klotho overexpression have on the murine eye. The majority 
of research has focused on the anti-aging effects of klotho and it’s ability to 
protect against cell senescence and oxidative damage [25, 28, 29]. As part of a 
screening study, an EFmKL46 klotho-overexpressing mouse was examined in 
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our laboratory and was observed to have substantial retinal vasculature leakage. 
This leakage was similar to that seen in rodent models of diabetic retinopathy.  
This observation and the fact that EFmKL46 mice are insulin resistant prompted 
a more detailed examination of the mouse’s retinal pathology and led to the 
subsequent development of this research project. While many rodent models of 
diabetic retinopathy exist, most models are both hyperglycemic and insulin 
dependent or resistant. The induction of both altered insulin signaling and excess 
glucose in animal models make it more difficult to determine the role each has in 
the induction of retinopathy.  
The overall objective of this project was to develop and/or utilize tools and 
techniques to study the klotho-overexpressing mouse and the expression of the 
klotho protein in murine eyes and human retinal cells. My first goal was to 
examine and characterize the ocular pathology observed in EFmKL46 mice. This 
was done using imaging techniques developed in the Haselton lab for the 
visualization of retinal vasculature in rodents and by various other methods 
employed by ophthalmologists to diagnose retinal anomalies in patients. 
Secondly, I needed to establish that the changes observed in these animals were 
caused by degeneration of the retina and not a developmental defect present 
from birth. This was done by examining young as well as aged EFmKL46 mice 
along with age and sex matched controls. As the EFmKL46 mouse has been 
shown to have altered insulin signaling, I aimed to correlate my findings with the 
ocular pathology commonly seen in diabetic patients and rodent models of 
deficient insulin signaling. To further support the hypothesis that the insulin-
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resistant, klotho-overexpressing mouse has potential as an animal model of 
diabetic retinopathy, antibodies to three different peptide sequences of the klotho 
protein were generated to examine the expression of the protein in both murine 
tissues and human RPE cells. Immunohistology and western blotting were 
employed to demonstrate the probable presence of klotho in these tissues. Dual 
staining of retinal whole mounts was used to detect pericytes in an attempt to 
further confirm the existence of vascular anomalies caused by altered insulin 
signaling.  
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CHAPTER II 
 
RETINAL DEGENERATION IN A KLOTHO-OVEREXPRESSING MOUSE 
 
Abstract 
PURPOSE:  The klotho-overexpressing mouse, EFmKL46, is an animal model of 
insulin resistance that is not hyperglycemic. In this study, we evaluate the 
retinopathy associated with altered insulin signaling in this transgenic animal.  
METHODS:  In four young (8-16 weeks) and 12 aged (70-80 weeks) EFmKL46 
mice along with age and sex matched wild type controls, the retinal vasculature 
was visualized by both fluorescence angiography and fundus photography. 
Photoreceptor function was evaluated by electroretinography (ERG). Tissue 
sections from post-mortem retinas were histologically examined for retinal layer 
anomalies and degeneration. 
RESULTS:  Aged EFmKL46 mice had abnormal retinal vasculature including 
tortuous veins, dot hemorrhages, and microaneurysms. Both hypo- and 
hyperpigmentation of the retina as well as possible retinal scarring and exudates 
were observed. ERG analysis showed decreased a- and b-wave amplitudes.  
Histological examination showed a wavy photoreceptor-retinal pigment 
epithelium (RPE) interface and degeneration of photoreceptors. The 
degeneration ranged from outer segment loss to the complete deterioration of the 
photoreceptor layer. The outer nuclear and outer plexiform layers were also 
reduced, and the remaining retinal layers were disorganized.  In aged EFmKL46 
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mice with complete photoreceptor loss, the RPE was thickened and showed 
areas of RPE proliferation. No retinal anomalies were observed in young 
EFmKL46 and young and aged wild type mice. 
CONCLUSIONS:  The klotho-overexpressing mouse has retinal pathologies 
consistent with those seen in other animal models of insulin dependent and 
insulin resistant diabetes. This animal model of insulin resistance without 
hyperglycemia is a promising tool for more detailed studies of pathologies 
associated with insulin signaling dysfunction. 
 
Introduction 
Diabetes mellitus produces characteristic changes in both the retinal 
vasculature and the neural retina. The vascular changes associated with 
diabetes in patients, such as breakdown of the blood retinal barrier, capillary 
microaneurysms, small intraretinal hemorrhages, and pericyte loss have been 
well documented [12, 19, 30]. Other hallmarks of the disease include basement 
membrane thickening, hard exudates, and/or cotton wool spots caused by the 
swelling of axons in the nerve fiber layer [14, 31]. As early as the 1960’s, 
Bloodworth [32] and Wolter [33] found that the diabetic condition also causes a 
loss of ganglion cells and degeneration of the inner layers of the human retina. 
Wolter postulated that neural retina degeneration occurs early in diabetes and 
may be the primary pathology that gives rise to later vascular changes [33]. 
Since inhibition of insulin signaling has been shown to promote apoptosis in the 
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neural retina [34], it has been suggested that failure of insulin/insulin-like growth 
factor (IGF) signaling may contribute to such retinopathy [17]. 
Rodent models of altered insulin signaling support the observations seen 
in patients. Studies of streptozotocin (STZ)-induced diabetic rats and mice have 
shown that neurons in the diabetic retina undergo significantly more apoptosis 
than those in control animals [14, 15, 33, 35]. These apoptotic neurons have 
been found mainly in the inner layers of the retina [14, 16, 19], but have also 
been observed in the outer nuclear and photoreceptor layers [14, 16]. Studies 
conducted with transgenic mice having mutations in the insulin 2 gene [17] or 
insulin receptor substrate (IRS) 2 [18] have shown similar results with loss of the 
inner retinal layers or outer nuclear and photoreceptor layers.  
The klotho-overexpressing mouse, EFmKL46, has an extended life span 
which is thought to be associated with perturbations in insulin and IGF-1 
signaling [25, 27]. Male klothos are hyperinsulinemic and insulin resistant. Both 
sexes are resistant to the hypoglycemic action of IGF-1 [26], have reduced 
GLUT4 translocation to the plasma membrane [27], and are not hyperglycemic. 
The klotho (kl) gene encodes a single pass membrane protein of 1014 amino 
acids with an extracellular domain composed of two internal repeats with 
homology to β-glucosidases [24]. The extracellular domain of klotho is cleaved 
and secreted into the blood. This fragment then binds to the cell surface and 
blocks or inhibits insulin signaling by suppressing tyrosine phosphorylation of 
insulin/IGF-1 receptors. While the protein does not prevent insulin from binding to 
its ligand receptors, the net effect is reduced IRS activity and reduced 
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association with PI-3 kinase. Thus, klotho blocks insulin signaling in a manner 
similar to the loss of insulin signaling seen in insulin resistance [27].  
While many rodent models of diabetic retinopathy exist, most models are 
both hyperglycemic and insulin dependent or resistant. The induction of both 
altered insulin signaling and excess glucose in animal models makes it more 
difficult to determine the role each has in the induction of retinopathy. In this 
paper, we characterize the ocular pathology present in the nonhyperglycemic, 
insulin resistant EFmKL46 mouse.  
 
Methods and materials 
 
Animals 
EFmKL46 and wild type mice were obtained from the University of Texas 
Southwestern Medical Center at Dallas [20]. The Institutional Animal Care and 
Use Committee at Vanderbilt University approved all animal experiments, and 
animals were treated in accordance with the ARVO Resolution on the Use of 
Animals in Research and Institutional Guidelines.  Mice weighing 20-50g were 
anesthetized with an intraperitoneal injection of ketamine/xylazine (87mg/kg/13 
mg/kg). Both eyes were dilated with one drop each of tropicamide (1%) and 
phenylephrine (2.5%) and covered with methylcellulose (2.5%) to prevent drying 
of ocular media. Fluorescence angiography, fundus photography, or ERG was 
then performed. Animals were euthanized by cervical dislocation, and the eyes 
were removed for sectioning. Paraffin sections were hematoxylin and eosin (H & 
E) stained to view histology. 
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Fluorescence angiography 
Angiography was performed as previously described [36]. Briefly, animals were 
anesthetized and their eyes dilated as described above. Mice were placed on the 
stage of an inverted fluorescence microscope (Nikon Eclipse TE2000-U, Nikon, 
Inc., USA) with the eye placed in a –6 diopter lens containing 2.5% 
methylcellulose to reduce light refraction. The microscope apparatus included a 
120 watt light source (EXFO X-Cite 120 Fluorescence Illumination System, 
EXFO, Ontario, Canada), a filter cube for excitation and emission of fluorescein, 
and a 4X objective (Figure 4). Each animal received a 50µL injection of sodium 
fluorescein (25mg/ml) intraperitoneally. Immediately after injection, retinal 
vessels of both eyes were imaged with a 3CCD digital camera (Hamamatsu 
C7780, Hamamatsu Photonics K.K., Hamamatsu City, Japan) and Image Pro 
software. 
 
Fundus photography 
After the mouse was anesthetized and its pupils dilated as described 
above, it was placed on an examination table and positioned below the lens of a 
Zeiss surgical microscope (OPMI 1-FC, Carl Zeiss, Inc., West Germany). A 90 
diopter lens was placed between the animal and the microscope and adjusted 
until the image of the retina was focused in the eyepiece.  A digital camera 
(Nikon D100, Nikon, Inc., USA) mounted to the surgical microscope was utilized 
to capture fundus images. 
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Figure 4. Diagram of fluorescence microscope configuration 
 
Electroretinography 
Following an overnight dark-adaptation period, electroretinograms were 
performed as previously described [37]. Briefly, animals were anesthetized and 
their eyes dilated as described above. A DTL silver/nylon fiber recording 
electrode (Diagnosys LLC, Littleton, MA) was placed on the corneal surface of 
each eye and held in place by a drop of methylcellulose. Needle electrodes 
placed subcutaneously in the forehead and tail served as reference and ground 
leads respectively. Mice were placed in front of a Ganzfield dome on a heated 
pad to ensure normal body temperature was maintained at 37°C. Rod-driven 
responses to light flashes covering an intensity range of 2.5-600.5 cd sec/m2 
were recorded by a visual electrodiagnostic system (UTAS-E 3000 with EM for 
Windows, LKC Technologies, Inc., Gaithersburg, MD). The responses were 
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dual fluorescence
filter cube
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video
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captu re card
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fluorescence
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amplified at 2500 µV and high and low pass filtered at 0.05 Hz and 500 Hz 
respectively. 
 
Results 
 
Histological studies revealed neural degeneration 
Histological sections from aged EFmKL46 indicated a disorganized retinal 
structure (Figure 5, D-H). Pathologic findings ranged from a loosely organized 
inner nuclear layer and patchy photoreceptors to the complete absence of outer 
plexiform, nuclear, and photoreceptor layers. Mild pathology was observed as a 
wavy RPE-photoreceptor interface, shortened outer segments, and patchy loss 
of inner segments of the photoreceptor layer (Fig. 5, D). The outer segments in 
two klotho mice were observed to be partly degenerated or absent (Fig. 5, E). 
The complete loss of photoreceptors as well as the outer nuclear and plexiform 
layers was seen in two thirds of the mice examined (Fig. 5, F-H). Hypertrophy of 
the RPE layer was observed in aged EFmKL46 mice, extending as far into the 
retina as the inner plexiform layer (Fig. 5, G-H). Extraneous pigmentation was 
present in the inner layers of the retina, including the ganglion cell layer, in three-
fourths of the aged klotho animals examined (Fig. 5, G). Sections from wild type 
mice (Fig. 5, A, C) and young EFmKL46 mice (Fig. 5, B) were similar to that of a 
normal mouse retina in both the central and peripheral regions.    
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                       F                                                G                                                  H 
Figure 5. Retinal Histology. Sections of young wild type (A), young EFmKL46 (B), and old wild 
type mice (C) are similar with well organized cell layers that are easily distinguished from 
adjacent layers. The pathology seen in aged EFmKL46 mice progresses from the outer to inner 
retina. Waves at the RPE-photoreceptor interface, outer segment shortening, and holes in the 
inner segments were observed with little change to inner retinal layers (D). In severe 
photoreceptor degeneration (E), the outer plexiform layer appears to be reduced as well. The 
complete disappearance of the photoreceptors, outer nuclear layer, and outer plexiform layer, 
and loss of ganglion cells is seen as retinal thickness continues to decrease (F-H). Proliferation of 
the RPE into the inner layers of the retina (G-H) and brown spots in the inner plexiform/ganglion 
cell layer were also seen (G). GCL=ganglion cell layer; IPL=inner plexiform layer; INL=inner 
nuclear layer; OPL=outer plexiform layer; ONL=outer nuclear layer; PR=photoreceptors; 
RPE=retinal pigmented epithelium. 
 
 
Fluorescence angiography showed vascular abnormalities 
Aged EFmKL46 mice exhibited several types of vascular pathologies 
including tiny hemorrhages in the microcirculation (Figure 6, C-D) and early 
retinal branch vein occlusions (Fig. 6, D, F).  Fluorescein leakage in the 
peripheral retina, neovascular tufting and microaneurysms were also observed 
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(Fig. 6, E-F). Fluorescein angiography performed on age and sex matched wild 
type (data not shown) and young EFmKL46 (Fig. 6, A-B) mice showed normal 
retinal vasculature.  
 
 
 
 
  
 
 
 
 
 
   A                                                              B 
 
 
 
 
 
 
 
 
 
 
  C                                                               D 
 
 
 
 
 
 
 
 
 
 
  E                                                                           F        
 
Figure 6.  Fluorescence angiography. The optic nerve head (A,C,E) and the peripheral retina 
(B,D,F) of both wild type/young EFmKL46 (A-B) and aged EFmKL46 mice (C-F) show very 
different vasculatures. The wild type mice have normal vessels and the microcirculation can 
clearly be seen in the peripheral photograph. Aged EFmKL46 show vascular anomalies (C-F). 
Abnormal central vascularutre (C) as well as small hemorrhages in the microcirculation and early 
retinal vein occlusions (D, F arrows) were observed. Leakage of the retina vessels as well as 
neovascularization and tufting also can be seen (E-F). 
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Fundus photography indicated retina damage 
 
In aged EFmKL46 mice (Figure 7, B-D), areas of hypo- and 
hyperpigmentation were observed in the periphery. Small, yellow spots were also 
present as well as areas of possible scarring (Fig. 7, C), non-profused and/or 
tortuous vessels, and abnormal color variation near the optic disk (Fig. 7, B).  A 
distinct line of demarcation existed between the hypo- and hyperpigmented areas 
(Fig. 7, D). In two-thirds of the animals examined, a haziness of the lens was also 
observed indicating the possible formation of a cataract. In wild type (Fig. 7, A) 
and young klotho mice (data not shown), the fundus images appeared normal, 
and no defects were observed.  
 
ERG recordings showed decreased rod response 
Aged EFmKL46 mice exhibited decreased a- and b-wave responses to all flash 
stimuli presented as compared to control animals (Figure 8). The amplitude of 
aged EFMKL46 a-wave responses peaked at 300 cd sec/m2 and then decreased. 
Control animal a-wave responses increased with stimulation intensity from 2.5–
600 cd sec/m2 (Fig. 8, C).  B-wave amplitudes for aged EFmKL46 had a very 
moderate increase and peaked at 450 cd sec/m2 while control amplitudes 
increased over the range of intensities examined (Fig. 8, D).  
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Figure 7. Fundus photography.  Both aged wild type and young EFmKL46 mice were observed to 
have normal retinas (A). Note the healthy blood vessels and striations of the neural layers. Hypo- 
and hyperpigmentation of peripheral retina (B, D) and areas of scarring (C*) were observed in 
aged EFmKL46 mice. Yellowish spots and brown pigmentation (B*) can be seen as well as 
tortuous vessels of the microcirculation (B, arrow) and a nonprofused vessel (B, ▲). Also note the 
paleness of the optic disc. A more peripheral view of B (D) shows the sharp contrast between the 
hypo- and hyperpigmented areas (D, ▼) as well as the vessels in the microcrculation (D, arrow). 
The hypopigmented area has the shape of a four-leaf clover.                                                              
B 
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Figure 8.  ERG data. Representative ERG signals recorded on the corneal surfaces of aged 
EFmKL46 and control animals at 600.5 cd sec/m2 (A-B). Both the a- and b-waves of the ERG 
waveforms show severely decreased response to light stimuli in aged EFmKL46 mice as 
compared to control animals (C-D). This effect can be seen more clearly at flash intensities 
greater than 2 log cd sec/m2. 
 
 
Discussion 
Aged EFmKL46 mice exhibit degeneration of the neural retina most 
prominently in the outer plexiform, nuclear, and photoreceptor layers. This is 
shown in histological sections (Figure 5) and supported by ERG data (Figure 8).  
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This result is consistent with the hypothesis that dysfunctional insulin signaling in 
the retina contributes to neural retina cell death, recently reviewed in Reiter and 
Gardner [10]. To date, one of the difficulties in obtaining experimental data in 
support of this hypothesis has been the development of a suitable animal model, 
as hyperglycemia is usually induced with the disruption of insulin signaling.  Aged 
EFmKL46 animals are insulin resistant, not hyperglycemic, and yet they 
characteristically show a loss of photoreceptors. 
Our findings correlate most closely with published studies on the IRS2-/- 
mouse model of insulin resistance. IRS 1 and 2 mediate many functions of insulin 
and IGF through the PI-3 kinase - Akt cascade [18], and insulin and IRS activity 
in the aged klotho mouse is severely decreased. Yi et al found that the IRS 2 
receptor was located in the outer and inner plexiform layers, ganglion cells, and 
inner photoreceptor segments, and IRS2-/- mice exhibited a loss of 
photoreceptors followed by uniform thinning of the outer nuclear layer [18].  
IRS2-/- mice normally die from extreme hyperglycemia, but β cell function 
was restored by transgenic expression in β cells of the nuclear transcription 
factor Pdx1 (IRS2-/-::Pdx1tg).  These mice are insulin resistant but do not develop 
diabetes. Results from partially rescued IRS2-/-::Pdx1tg animals closely match our 
findings and support the hypothesis that dysfunction of the insulin/IGF signaling 
cascade, rather than hyperglycemia, induces photoreceptor loss. These animals 
displayed a progressive loss of photoreceptors, reduction of the outer nuclear 
layer, and moderate loss of inner retinal layers with all retinal layer loss occurring 
after photoreceptor degeneration. In the same study, IRS1-/- mice that developed 
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glucose intolerance but not diabetes showed no changes in the retina [18]. Yi et 
al proposed that the IRS 2 receptor promotes photoreceptor survival by inhibiting 
the caspase activation cascade, as activated caspase 3 correlates with 
photoreceptor degeneration in several rodent models and accumulates in the 
retina of IRS2 -/- mice. Determining caspase 3 levels in aged klotho mice has not 
been done but would provide additional biochemical data to evaluate this 
hypothesis.  
Several other published reports suggest that insulin resistance, apart from 
hyperglycemia, causes neural retina degeneration. Insulin reduces neuronal cell 
death in cerebral ischemia independent of blood glucose levels [38]. In addition, 
antibodies that inhibit insulin signaling have been shown to promote apoptosis of 
the neural retina [34].   
Other models of the diabetic state have shown some of the pathology we 
observed in aged klotho mice. For example, loss of the blood retinal barrier and 
reduction of the inner layers of the retina was documented in hyperglycemic mice 
with a point mutation of the insulin 2 gene [17]. In one study of STZ-treated rats, 
a slight thinning of the inner retina, a gross reduction in outer nuclear layer 
thickness, and the death of photoreceptors were shown as the duration of insulin-
dependence increased [14]. Others found a degeneration of the inner plexiform 
layer as well as the photoreceptor and RPE layers in STZ rats [16], or reported 
loss of inner nuclear and plexiform layers with ganglion cell loss [19]. Mice made 
insulin dependent with STZ were found to have loss of ganglion cells and inner 
and outer nuclear layers [15].  
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After the photoreceptors and outer nuclear and plexiform layers of aged 
EFmKL46 mice are lost, RPE infiltration and proliferation into the inner layers of 
the retina was observed (Figure 5, F-H). These changes could be attributed to 
deterioration of the blood retinal barrier as fluorescein leakage was seen during 
angiography testing (Figure 6, C-F). To maintain proper homeostasis of the 
retina, the RPE must preserve its integrity and protect the neural layers from the 
open circulation of the choroid. When the blood retinal barrier is disrupted, 
growth factors, proteins, and other molecules can pass unregulated between the 
two environments. While the klotho protein is highly specific for insulin/IGF-1, it 
does not affect the binding or activity of other growth factors such as epidermal 
growth factor (EGF) and platelet-derived growth factor (PDGF) [25]. PDGF has 
been found to be one of the main chemoattractants for RPE cells, and EGF can 
stimulate proliferation of epidermal and epithelial cells. The response to EGF is 
enhanced under hypoxic conditions in which the number of receptors per cell 
increases [39], and patients suffering from diabetes have increased EGF and 
PDGF levels [40].  
Abnormalities of the fundus and decreased a- and b-wave amplitudes 
were only observed in aged klotho mice. Vascular anomalies detected with 
angiography and fundus photography were seen only in aged EFmKL46 mice 
with degenerated outer retinal layers. These findings correlate well with reports 
that have found retinal degeneration occurs in the neural retina before vascular 
changes become apparent [12, 14, 15, 19]. The severity of retinal histological 
changes correlates closely with the degree of vascular and pigmentation 
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anomalies and decreased neural signaling observed with the diagnostic 
techniques used in this study. As with patients, the retinal pathologies seen in 
aged EFmKL46 mice vary among animals. Future studies are needed to further 
elucidate the reason(s) for animal-to-animal variation.  
Microaneurysms, diffuse leakage, dot hemorrhages, and tortuous veins 
were observed with fluorescence angiography and fundus photography in aged 
klotho mice. These vascular changes are among the main complications of 
diabetic retinopathy and are thought to be the result of metabolic damage to 
vascular endothelial cells [30]. Although hyperglycemia is most often the 
strongest predictor of diabetic complications, several well-documented cases of 
diabetic retinopathy have been described in patients without overt hyperglycemia 
or glucose intolerance [10]. These cases suggest that insulin resistance may be 
required for the development or progression of retinopathy.  
The retinal pathologies observed in aged EFmKL46 mice appear to be the 
result of a progressive degeneration, not a developmental defect. As can be seen 
in Figure 5, young EFmKL46 mice have retinas similar to young and old wild type 
mice with complete development of all retinal layers. Fluorescence angiography 
and fundus photography in Figures 6 and 7 show no observable vascular 
anomalies in young klothos. 
Previous studies on the EFmKL46 mouse have explored the biochemical 
basis for their increased longevity. Kuro-o et al recently published data 
suggesting that klotho-induced insulin resistance increases their lifespan [25].  
Kuro-o et al have demonstrated that the klotho protein in the EFmKL46 mice 
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binds to cell surface receptors and results in resistance to insulin and IGF-1. Its 
mechanism is believed to be the suppression of tyrosine phosphorylation of 
insulin/IGF-1 receptors, which leads to the reduction of IRS activity and 
association with PI-3 kinase. This mechanism has been hypothesized to be 
beneficial for peripheral tissue by preventing cellular lipid overload via reduction 
of the insulin-stimulated availability of glucose. A reduced intracellular lipid 
content could raise the apoptotic threshold and extend the life of cells [27]. 
However, our data suggests that the altered signaling appears to result in the 
loss of photoreceptors and further retinal degeneration.  
In summary, the retinal pathology exhibited by the aged EFmKL46 mouse 
has characteristics similar to those seen in patients with diabetes and rodent 
models of altered insulin signaling. The principle observation is loss of 
photoreceptors, which occurs in all aged klotho mice. More severe pathology 
such as vascular leakage and RPE proliferation is variable among animals. 
Based on comparisons with published studies, our results are consistent with the 
hypothesis that dysfunction of the insulin/IGF-1 signaling cascade, rather than 
hyperglycemia, is responsible for neuronal cell death in the retina. The klotho-
overexpressing mouse is a promising animal model for further detailed studies of 
retinal pathologies associated with altered insulin signaling and may prove useful 
for specifically studying the role insulin and IGF-1 in retinal function and 
maintenance.  
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CHAPTER III 
 
SUMMARY AND FUTURE WORK 
 
In summary, the retinal pathology exhibited by the aged EFmKL46 mouse 
has characteristics similar to those seen in patients with diabetes and rodent 
models of altered insulin signaling. The principle observation is loss of 
photoreceptors, which occurs in all aged klotho mice. More severe pathology 
such as vascular leakage and RPE proliferation is variable among animals. 
Based on comparisons with published studies, these results are consistent with 
the hypothesis that dysfunction of the insulin/IGF-1 signaling cascade, rather 
than hyperglycemia, is responsible for neuronal cell death in the retina.  
Future studies on the EFmKL46 mouse would contribute to a better 
understanding of the animal and the biological cause(s) of its retinal pathology. 
The effects altered insulin signaling has on the eyes of female EFmKL46 mice 
have not been examined. These animals are resistant to IGF-1 but not insulin. 
While insulin and IGF-1 are believed to have similar mechanisms of action, they 
are not identical. Since the longevity of EFmKL46 females may be induced 
without altering insulin levels or actions [26], these mice could exhibit different 
ocular pathologies. If this is shown to be the case, a comparison between the 
sexes would be of use. The changes seen in males versus females could be 
categorized and then compared to hypothesize how the resistance to each 
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hormone contributes to ocular pathology. This could help determine the role  
IGF-1, as opposed to insulin, has on the degeneration of the retina. 
EFmKL48 mice have also been found to be insulin and IGF-1 resistant. 
These animals overexpress the klotho protein, but the transgene has been 
inserted in a different, unknown location in the genome. Due to access limitations 
at the time of this project, no experimentation could be performed on these 
animals. Conducting the same type of experiments with EFmKL48 mice and 
comparing results to EFmKL46 could bring to light possible difference between 
the two strains. Observing the same ocular pathologies in both strains would also 
help to confirm that the changes observed in EFmKL46 mice are, in fact, due to 
insulin/IGF-1 resistance and not the disruption of an unknown gene by the 
insertion of the klotho transgene. 
 Samples from the vitreous of klotho-overexpressing mice could also be 
obtained to determine the levels of glucose, insulin, and growth hormones such 
as EDF, PDEGF, VEGF, and then compared to controls animals. These growth 
hormones have been found to induce the proliferation and migration of RPE cells 
in vitro and are present in diabetic patients’ plasma and serum at higher 
concentrations than in nondiabetic patients. These growth factor levels could be 
measured to determine if the growth factor levels are also increased in the 
insulin-resistant EFmKL46 mouse as compared to wild type mice.  
Preliminary work with three polyclonal antibodies for the klotho protein has 
also been performed and is documented in Appendix A. This work indicates that 
both the membrane and splice variant forms of the klotho protein are potentially 
 31 
 
 
present in both the retinas of EFmKL46 and control C57BL/6 mice, and human 
RPE cells. Future work should be focused on confirming the specificity of these 
antibodies. This could be done by repeating the experiments detailed in 
Appendix A with the monoclonal antibodies KM2076 and KM2119 [21]. These 
have been proven to recognize the membrane and splice variant forms in 
humans and mice in western blot and immunofluorescent applications. Also, 
additional western blots should be performed with our antibodies to confirm the 
preliminary results presented in Appendix A. Immunohistochemistry should also 
be done with wild type mouse kidneys [20, 21, 41], and human kidney and eye 
tissue to further substantiate our antibodies’  validity. While these antibodies may 
not prove useful for western blotting, they may still have utility for 
immunohistochemistry.  
Confirming the specificity of our antibodies will then enable them to be 
used for a variety of experiments such as discovering expression of the klotho 
protein in the retinas of humans, determining its location in the mouse retina, and 
differentiating which form of the protein is present. This work could also lead to 
further studies on the interaction of klotho with insulin receptors in the eye. 
Cellular experiments could also be conducted to elucidate the effect increased or 
decreased klotho expression has on cells such as the RPE. Oxidative stress 
testing, for example, could be conducted to determine if cell senescence is 
reduced in RPE cells that overexpress the protein. 
Pericyte loss has also been preliminarily examined and is documented in 
Appendix C. These results are inconclusive. Neither the presence nor loss of 
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pericytes could be definitively confirmed. Future work should refine the staining 
procedure employed or a standard trypsin digest of the retina should be used to 
determine if EFmKL46 mice have pericyte loss. As pericyte dropout is one of the 
hallmarks of diabetic retinopathy, this finding could clarify whether this cell type is 
being lost in the insulin resistant EFmKL46 mouse or if other mechanisms should 
be explored to explain the pathology.
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APPENDIX A 
 
KLOTHO ANTIBODIES AND IMMUNOSTAINIG 
 
Introduction 
 
Klotho has been shown to extend the lifespan of EFmKL46 and EFmKL48 
mice, animals genetically engineered to overexpress the protein, through the 
reduction of insulin/IGF1 signaling [25, 27]. The mouse klotho gene encodes for 
a single-pass membrane protein of 1,014 amino acids (a.a), which consists of an 
N-terminal signal sequence, a putative extracellular domain with two internal 
repeats (KL1 and KL2), a single membrane spanning region, and a short 
intracellular region (Figure 9).  
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Figure 9. Mouse klotho membrane protein structure. SG= signaling sequence, 
KL1= first klotho repeat, KL2= second klotho repeat, TM=transmembrane 
regionn, INT= intracellular region, a.a.=amino acid. 
 
 
 
The internal repeats share homology with β-glucosidase enzymes. The human 
homologue of klotho has 86% amino acid identify to the mouse klotho protein 
and is 1,012 a.a. in length [22]. The protein has been detected in the pituitary 
gland, placenta, skeletal muscle, bladder, aorta, pancreas, testis, ovary, colon, 
and thyroid gland of mice and the kidney, placenta, prostate, and small intestine 
in humans [21]. Due to the limited expression of klotho in the body but the 
manifestation of its effects on a number of organs, scientists hypothesize that the 
protein or some unidentified associated factors produce its effect through the 
circulatory system. It has been determined that the extracellular domain of klotho 
is shed from the cell surface and is detectable in blood and cerebrospinal fluid of 
humans and mice [23]. The protein has a short stretch of basic amino acids (lys-
lys-arg-lys) between the two internal repeats of the extracellular domain in both 
mouse and human that is a possible site for the proteolytic cleavage.  A splice 
SG: a.a 1-28 
KL1: a.a 29-533 
KL2: a.a 534-981
TM: a.a 982-1,002 
INT: a.a 1,003-1,014 
(extracellular) 
(intracellular) 
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variant of the kl mRNA also exists which encodes for a secreted protein ~ 550  
a.a. long in mice and humans.  
 
                                         
Figure 10. Mouse klotho splice variant protein structure. SG= signaling 
sequence, KL1= first klotho repeat, SPV= a.a. unique to splice variant. 
 
 
 
This form lacks the second internal repeat (KL2), the transmembrane domain 
and the intracellular domain. The secreted splice variant form of klotho has been 
found to predominate over the membrane form in all tissues examined in 
humans. The inverse is true in wild type mice where membrane-bound klotho 
expression is 10 or more times greater than the splice variant [24].   
Recent work has shown that the klotho protein has anti-apoptotic and anti-
senescence effects on vascular endothelial cells [28]. However, studies in our lab 
have shown that aged EFmKL46 mice have disruption and proliferation of the 
retinal pigment epithelium as well as retinal degeneration hypothesized to be the 
result of apoptosis. In this work, we sought to explore the potential expression 
and distribution of the klotho protein in the mouse eye and human RPE cells.  
  
 
SG: a.a 1-28 
KL1: a.a 29-533
SPV: a.a 534-549 
(extracellular) 
(cell membrane) 
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Methods and materials 
 
Antibodies 
Polyclonal antibodies were generated to three different peptide sequences 
of the human klotho protein [42]   (Zymed Laboratories, San Francisco, CA). KL-I 
((C)YYSKKGRRSYK-COOH) corresponded to amino acids (a.a.) 1002~1012 
located in the intracellular domain; KL-S ((C)SQLTKPISSLTKPYH-COOH) 
corresponded to a.a. 535~549, which were unique to the splice variant of the 
protein, and KL-B ((C)SGTTKRDDAKYMYY-NH2) corresponded to a.a. 420~433 
located in the first klotho repeat (KL1) of the extracellular domain. Mice and 
humans share 80% homology for the protein (ref). NCBI Basic Local Alignment 
Search Tool (BLAST) was utilized to ensue that these a.a. sequences were 
homologous to other proteins found in rodents or humans. Other primary 
antibodies used were specific for NG2 and biotinylated lectin. Secondary 
antibodies used were Alexa Fluor 488, 568, and 680 conjugated goat anti-rabbit 
IgGs. 4,6-diamidine-2-phenylindole dihydrochloride (DAPI) nucleic acid stain was 
also used (Molecular Probes, Eugene, Oregon). 
 
Cell Culture 
All experiments were performed using ARPE-19, a human retinal pigment 
epithelium cell line (ATCC, Manassas, VA). Cells were seeded at a density of 
15,000/cm2 on 4-chamber slides, and cultures were maintained for 2 or 3 days. 
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on slides and 1 week in plates. DMEM medium supplemented with 10% fetal 
bovine serum was changed twice a week. 
 
Immunofluorescence 
Immunohistochemistry was conducted to determine the expression and/or 
localization of the klotho protein in ARPE-19 cells and mouse retinal tissue. Cells 
grown on 4-chamber slides were fixed with 70% methanol for 15 minutes, rinsed 
with PBS and permeabilized with 0.25% Triton X-100 for 10 minutes, and 
blocked with a solution of 2% BSA in 1X PBS for 1.5 hours at room temperature. 
Frozen tissue sections from aged EFmKL46 and C57BL/6 mice retinas were 
fixed and permeabilized in the same manner. Frozen sections were blocked with 
a solution of 5% bovine serum and 2% BSA in PBS overnight at 4°C. Primary 
klotho antibodies were then added at a dilution of 1:250 and incubated overnight 
at 4°C. After being washed three times with PBS, the secondary antibody and 
DAPI were added to the sample at dilutions of 1:1500 and 1:2000 respectively. 
After a 4-hour incubation period at room temperature, slides were washed five  
All slides were examined with an inverted fluorescence microscope (Nikon 
Eclipse TE2000-U, Nikon, Inc., USA) with an EXFO X-Cite 120 Fluorescence 
Illumination System. Pictures were taken with a 3CCD Digital Camera 
(Hamamatsu C7780, Hamamatsu Photonics K.K., Hamamatsu City, Japan) and 
Image Pro software.   
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Western blotting 
Since the kidney is one of the primary organs to express the klotho protein 
in mice, western blotting was conducted on kidney lysates to test the validity of 
the three generated antibodies. Eye lysates were used to determine if the klotho 
protein was present in the murine eye. Frozen eye and kidney tissues from 
C57BL/6 mice were homogenized in lysis buffer ([1% Triton X-100, 10%glycerol, 
1% NP-40, 50 mM Hepes, pH 7.4, 100 mM sodium pyrophosphate, 100 mM 
sodium fluoride, 10 mM EDTA, 5 mM sodium vanadate, aprotinin (10 µg/ml), 
leupeptin (5 µg/ml), benzamidine (1.5 mg/ml), and PMSF (34 µg/ml]) [43] using a 
sonic dismembrator (Fisher Model 100, Fisher Scientific) at a speed of 2 for 10 s 
intervals. The insoluble material was removed by centrifugation at 14,000 rpm for 
1.5 hours. 20 µg of supernatant proteins measured by BCA protein assay kit 
(Pierce Biotechnology, Inc., Rockford, IL) were separated on SDS-PAGE gel 
(10%) and transferred electrophoretically to a PVDF membrane. Blots was 
blocked in PBS with 0.1% Tween 20 and 2% bovine serum albumin for 1 hr at 
room temperature and incubated with 1 µl/ml of each primary antibody overnight 
at 4˚C. They were then washed and subjected to treatment with the secondary 
antibody at a dilution of 0.2 µl/ml for 45 minutes. Blots were washed again and 
then dried. Bands were visualized with the Odyssey Infrared Imaging System (LI-
COR, Biotechnologies, Lincoln, NE). 
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Results 
 
Western blot analysis of klotho protein 
Western blot analysis produced multiple bands from both eye and kidney 
lysates when probed with the KL-I antibody (Figure 11, A). Dual bands of ~35 
and ~ 90 kDa were detected for eye and kidney lysates. Eye lysates also showed 
lower bands estimated to be 22 and 33 kDa. A band between 93 and 115 kDa 
was also detected from kidney lysates. Bands detected from eye lysates with  
KL-S roughly correspond to the two lower bands from eye lysate detected with 
KL-I (Fig. 11, B). Their sizes were estimated to be 22 and 35 kDa. A possible 
band was also detected for 115 kDa. The faint bands appearing on the blot 
between 50 and 93 kDa are an image artifact. They are not as dark on the 
original scan of the blot and are believe to be the result of formatting and 
transferring the image. No bands were visualized from the kidney lysate using 
KL-S (data not shown). No bands were detected with KL-B (data not shown). 
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Figure 11. Western blots. Multiple bands were detected with KL-I from eye and kidney lysates (A). 
Dual bands were detected for ~35 and ~90 kDa. Additional bands of ~22 and ~33 kDa were also 
detected from eye lysates. KL-S only detected bands from eye lysates at ~22 and ~35 kDa (B). A 
possible band was detected for 115 kDa. E=eye; K=kidney. For more information, see blue binder 
in Haselton lab. 
 
 
 
Klotho protein localized in RPE cells 
Antibody staining revealed that the klotho protein was present in both the 
nucleus and cytoplasm of the RPE cell (Figure 12). Staining with KL-I produced a 
pattern of dark cytoplasm and bright nuclei that contained small punctate vesicles 
(Fig. 12, B). Nuclear membrane localization was also observed, seen as a bright 
ring around the nucleus. KL-S yielded the inverse of KL-I staining (Fig. 12, C). 
This pattern consisted of dark nuclei surrounded by granular, cytoplasmic 
staining. The protein appeared to be concentrated around the nucleus of the cell 
and diffused outward toward the cell membrane. Staining with the KL-B antibody 
produced a combination of the patterns seen with KL-I and KL-S (Fig. 12, D). 
 E               K    E
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Dark nuclei containing faint, punctate vesicles were observed. The protein was 
concentrated around the nuclei and present throughout the cytoplasm. In 
confluent cells, the cell membrane was partly outlined by punctate granules. 
Cells stained with secondary antibody only showed no immunoreactivity (Fig. 12, 
A). 
 
 
 
 
 
 
     
      A                                                              B 
 
 
 
 
 
 
    
     C                                                               D 
 
 
Figure 12. Immunofluorescent microscopy of ARPE cells. Control cells stained with 2° antibodies 
only (A). Cells stained with KL-I have dark cytoplasm and bright nuclei with punctate granules 
inside the nucleus (B, arrow) while KL-S staining gives a bright cytoplasm that surrounds a dark 
nucleus (C). KL-B staining gives a combination of KL-I and KL-S (D). Note the dark nuclei and 
punctate granules both in the cytoplasm, and on the cellular membrane (D, ▲).    
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Klotho staining of frozen sections 
Staining of aged EFmKL46 and C57BL/6 retinal tissue produced 
inconclusive results (Figure 13). All neural layers of sections stained with only 
Alexa Fluor 488 were bright green (Fig 13, A). The cornea and choroid were also 
stained (data not shown). Immunostaining with KL-I gave results similar to the 
control staining seen in Figure 13, A (data not shown). Sections stained with KL-
B and KL-S were also observed to have green neural layers, cornea, and choroid 
but fluoresced more brightly than controls (Fig 13, B-C). The outer limiting 
membrane and the membranes of cells located in the nuclear layers of the retina 
appeared to be more clearly distinguished with KL-B staining (Fig 13, B). Cell 
membranes were also more easily seen in sections stained with KL-S (Fig 13, 
C). Alexa Fluor 568 was used in an attempt to minimize background illumination 
caused by autofluorescence of the retinal tissue. C57BL/6 control retinas stained 
with only the secondary antibody produced results similar to those observed with 
only Alexa Fluor 488 used on EFmKL46 tissue (Fig 13, D). All retinal layers 
appeared red. These results were also observed for KL-I and KL-B staining (data 
not shown). KL-S staining allowed the visualization of individual cells in the 
nuclear layers of the retina (Fig 13, E). The protein appeared to be on the 
membrane of the cell.  
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Figure 13. Immunofluorescent microscopy of frozen sections. Retinal tissue from aged EFmKL46 
(A-C) and C57BL/6 (D-E) were stained with each klotho antibody. Sections stained with Alexa 
Fluor 488 only (A) were autofluorescent and all retinal layers appeared green. KL-B (B) and KL-S 
(C) staining gave a brighter signal and allowed for better visualization of the nuclear layers of the 
retina. KL-I antibody staining (data not shown) produced results similar to the control (A). 
C57BL/6 sections were stained with Alexa Fluor 568 in an attempt to minimize autofluorescence 
(D-E). KL-B and KL-I antibodies showed a staining pattern similar to the control stained with 
secondary only (D). KL-S allowed for better visualization of nuclear layers (E) but the image 
brightness was the same as in the control. Arrows indicate the photoreceptor layer. 
 
 
 
Discussion 
The presence of the klotho protein in the eye has not been previously 
studied. Western blotting and immunohistochemistry yielded promising results. 
Blots probed with the KL-I antibody specific for the intracellular portion of the 
klotho protein indicate 35 and 90 kDa bands in both the eyes and kidneys of 
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C57BL/6 mice. These numbers are far below the reported values of 120 and 135 
kDa [21-24, 42]. One possible explanation is that the extracellular part of the 
protein has been shed at the cell surface and the antibody is detecting the 
remaining intracellular fragment. KM2119, an antibody specific for the second 
klotho repeat, has recognized a 60 kDa protein as well as a 130 kDa protein in 
mice and humans kidneys [21]. These scientists hypothesized the 60 kDa band 
was the result of cleavage of the membrane form. Part of the membrane protein 
had been cleaved, and the antibody was recognizing the remainder of the protein 
near the KL2 domain. The length of the protein fragment containing only the 
intracellular domain, in theory, would be shorter than a fragment that also 
contained the KL2 domain. As KL-I detected a 35 kDa band, this theory is 
plausible. The 90 kDa band detected in this work by KL-I in kidney lysate could 
be the result of cleavage of the extracellular domain at a different sight or the 
aggregation of two or more intracellular fragments.  The more likely explanation 
is denaturation of the protein sample. However, it still remains to be determined if 
KL-I is actually detecting the klotho protein or the bands are a result of 
nonspecific binding. The lower band of 22 kDa detected in eye lysates with KL-I 
also remains to be explained.  
KL-S, specific to the sequence of amino acids unique to the splice variant 
of the klotho protein, detected bands from eye lysates at ~ 22 and 35 kDa. These 
bands are roughly the same size as those detected with KL-I. An established 
antibody to the first klotho repeat (KM2076) has recognized a 130 kDa protein in 
wild type mice and human kidneys. This could be the full length of the klotho 
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protein or the splice variant as both include KL1. While the splice variant has only 
half the amino acids of the membrane-bound protein, the exact size of the splice 
variant has yet to be determined. KL-S did not detect the splice variant in the 
kidney lysate of mice. This may be due to the fact that the membrane form of 
klotho is expressed ten-fold that of the splice variant in all mouse tissue 
previously examined [24]. Therefore, the concentration of the splice variant was 
not great enough to be detected in the amount of kidney lysate used in this study.  
Immunohistochemistry of RPE cells with the three klotho antibodies used 
in this study produced promising results. The antibody specific for the 
intracellular portion of the membrane protein, KL-I, localized this a.a. sequence in 
the nucleus of the cell. The extracellular portion of the membrane protein is 
broken off and secreted, and it is not known if the remainder of the protein 
remains attached to the cell membrane. This pattern of staining could indicate 
that the intracellular portion of the protein is released into the cytoplasm of the 
cell and is taken up by the nucleus. The punctate staining seen within the 
nucleus could indicate that the intracellular part of the protein is forming 
aggregates. 
The secreted (or splice) variant of the protein is rarely mentioned in recent 
literature. Our antibody, KL-S, detected the splice variant form of the klotho 
protein in the cytoplasmic region of the cell. This form of the klotho protein 
appears to be more abundant in RPE cells than the membrane form detected 
with KL-I. This finding correlates with previous studies that determined the splice 
variant predominates over the membrane form in all tissue examined in humans, 
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such as the brain, prostate, and kidney [42].  As the retina can be thought of as 
an extension of brain, it is plausible that klotho is also abundant in the eye. 
Immunostaining of RPE cells with the KL-B antibody produced a 
combination of KL-I and KL-S results. As KL-B is specific for the first extracellular 
repeat (KL1), the antibody appears to be detecting both the secreted splice 
variant and the membrane form. KL-B also detected the klotho protein in vesicles 
on the cell membrane. This may indicate that the extracellular domain of klotho 
is, in fact, being shed at the cell surface in RPE cells and supports the report that 
suggests that the secreted form of the membrane protein forms dimers and 
trimers and may group together to form aggregates [23].  
The results from the frozen section staining can be interpreted in a variety 
of ways. The control staining with only a secondary antibody gave a fluorescent 
signal but visualization of the specific neural layers was not very clear. This could 
be attributed to autofluorescence of the retinal tissue, nonspecific binding or the 
secondary, or the inability to focus adequately due to the thickness of the tissue 
section. KL-B and KL-S appear to be located on the outer limiting membrane as 
well as the membranes of the cells located in the nuclear layers. This could 
indicate that klotho is, in fact, found on the cell surface of these cells in the retina 
especially since KL-B is specific for extracellular portion of the protein. The splice 
variant is also secreted at the cell surface and could account for KL-S staining. 
 As all the frozen retinal tissue fluoresced to some degree, it is difficult to 
determine how specific the antibodies are in the sections. As the retina 
fluoresces most around the 488 wavelength, Alexa Fluor 568 was used in 
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attempt to minimize the background effect, but with little success. Antibody and 
control staining gave very similar results. KL-S staining did allow for the 
visualization of the cell membranes in the nuclear layers, but KL-I and KL-B did 
not. This result is surprising as the membrane-bound fraction of klotho is more 
prominent in mouse tissue than the splice variant. 
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Appendix B 
 
Table 1.  Storage and use of klotho antibodies. 
 
SPL: splice variant, INT: intracellular, KSCN:, (+++): best for use, (++): adequate, (+): poor results, (-):no result. See pp. 44-46,54-56, 86-96 of  
lab book for additional details. 
 
 
Klotho Antibodies (Rabbit) 
Antibody tests Antibody results  
Peptide Sequence 
 
Animal 
 
Type 
 
Fraction 
 
Antibody 
labels 
 
Amount 
(mL) 
 
Concentration 
(mg/mL) 
 
Storage 
(-20˚C) 
RPE western RPE western 
 
KSCN 
 
1bk 
 
13.91 
 
1.00 
Original 
Tube 
 
X 
 
X 
 
+++ 
 
++ 
 
1b 
 
SPL 
(KL-S)  
Glycine 
 
1bg 
 
5.93 
 
1.00 
Original 
Tube 
 
X 
  
+ 
 
 
KSCN 
 
2bk 
 
13.20 
 
0.45 
Original 
Tube 
 
X 
  
++ 
 
 
 
(C)SQLTKPISSLTKPYH-
COOH 
 
A.A. #535-549 
 
Klotho b 
 
2b 
 
SPL 
(KL-S)  
Glycine 
 
2bg 
 
5.10 
 
0.40 
Original 
Tube 
 
X 
  
+ 
 
 
KSCN 
 
1ck 
 
10.98 
 
1.00 
Original 
Tube 
 
X 
  
++ 
  
1c 
 
INT 
(KL-I)  
Glycine 
 
1cg 
 
8.20 
 
0.18 
Original 
Tube 
 
X 
  
+ 
 
 
KSCN 
 
2ck 
 
14.91 
 
1.00 
0.5 mL 
aliquots 
 
X 
 
X 
 
+++ 
 
+++ 
 
 
(C)YYSKKGRRSYK-COOH 
 
A.A.#1002-1012 
 
Klotho a 
 
2c 
 
INT 
(KL-I)  
Glycine 
 
2cg 
 
6.10 
 
0.59 
Original 
Tube 
 
X 
  
++ 
 
 
KSCN 
 
1dk 
 
6.90 
 
0.93 
Original 
Tube 
 
X 
  
+ 
  
1d 
 
BOTH 
(KL-B)  
Glycine 
 
1dg 
 
6.00 
 
0.87 
Original 
Tube 
 
X 
  
+ 
 
 
KSCN 
 
2dk 
 
27.95 
 
1.00 
Original 
Tube 
 
X 
 
X 
 
+++ 
 
- 
 
 
(C)SGTTKRDDAKYMYY-NH2 
 
A.A. #420-433 
 
Klotho a/b 
 
2d 
 
BOTH 
(KL-B)  
Glycine 
 
2dg 
 
6.00 
 
0.67 
Original 
Tube 
 
X 
 
X 
 
+ 
 
+ 
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APPENDIX C 
 
PERICYTE STAINING IN RETINAL WHOLE MOUNTS 
 
Pericyte loss is one of the earliest cellular lesions seen in diabetic 
retinopathy. These cells surround capillary tubes in the retinal microcirculation 
and normally exist at a 1:1 ratio with endothelial cells.  They are believed to serve 
a contractile function, help control the flow of blood through the capillaries, and 
possibly help maintain the blood retinal barrier. Pericyte dropout is usually 
observed in areas with nonperfused capillaries and microaneurysms. Pericyte 
loss may also account for a change in blood-retinal barrier permeability, one of 
the earliest signs of diabetic retinopathy [4].   
Whole retinas were from aged EFmKL46 and C57BL/6 mice were 
removed from the eye, placed in 8-chambered slides, and washed with PBS-T 
(1% Triton X-100). PBS-T was then removed and the retinas were blocked 
overnight at 4°C in a solution of 1% Triton X-100, 5% horse serum, and 0.215% 
BSA in PBS. NG2 and biotinylated lection primary antibodies were added at 
concentration of 1:100 and 1:50 respectively and incubated overnight at 4°C. 
Retinas were washed with PBS three times for three minutes each. Streptavidin - 
Cy5, Alexa Fluor 555, and DAPI were then added to the samples at dilutions of 
1:25, 1:1000, and 1:2000 respectively and incubated for 2 hours at room 
temperature. Retina were washed five times with PBS for 3 minutes each and 
covered with a coverslip. All slides were examined with an inverted fluorescence 
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microscope (Nikon Eclipse TE2000-U, Nikon, Inc., USA) with an EXFO X-Cite 
120 Fluorescence Illumination System. Pictures were taken with a 3CCD Digital 
Camera (Hamamatsu C7780, Hamamatsu Photonics K.K., Hamamatsu City, 
Japan) and Image Pro software.   
 Aged C56BL/6 and EFmKL46 sections stained with NG2, biotinylated 
lectin, and DAPI gave similar results (Figure 14). NG2, an antibody specific for 
pericytes, gave poor staining results. The entire retina was red and pericytes 
could not be distinguished from other retinal tissue. Biotinylated lectin biotinylaed 
lectin stained retinal tissue as well as vessels red. However, the 
microvasculature could be distinguished. DAPI staining showed not only cells 
located along the walls of the microvessels as well as cells of the neural retina. 
Elongated cells lining the vessel wall were hypothesized to be pericytes due to 
their shape and location. C57BL/6 mice appeared to have more pericyte 
coverage along the length of the microvessels (Fig 14, A). EFmKL46 had less 
cellular localization along the vessel walls. Cells were also smaller and had a 
more circular morphology (Fig 14, B). Pericyte coverage was determined by 
visual inspection only. No quantative information could be gained from the 
images. 
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A 
 
                                                            B                                                                               
Figure 14. Pericyte staining of retinal whole mounts. Microvessels and cell nuclei were observed 
with immunostaining of aged C57BL/6 (A) and EFmKL46 (B) retina. C57BL6 had elongated nuclei 
that lined the outer edges of the blood vessels (A). The nuclei of other cells of the retina had a 
more rounded shape. EFmKL46 were also observed to have nuclei on the outer edge of the 
vessels. A few were elongated but most had a round morphology (B). Wide arrows indicate 
microvessels. Narrow arrows indicate possible pericytes. 
 
 
 
Pericyte staining was very inconclusive. The NG2 antibody and its Alexa 
Fluor 568 secondary stained the entire retina red. Pericytes could not be 
definitively distinguished from the other retinal tissue. DAPI staining allowed for 
the localization of cell nuclei, but because the presence of pericytes could not be 
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confirmed, it is not known if the cells lining the microvessels are pericytes or 
another cell types. The elongated morphology of these vessel-lining cells is seen 
more in C57BL/6 than EFmKL46 retinas and pericyte loss is once of the 
landmarks of diabetic retinopathy. If these cells are, in fact, pericytes, this finding 
would help to further confirm that the vascular changes seen in aged EFmKL46 
mice are the result of altered insulin signaling. 
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